DoD can't continue to ignore this conflict of interest that arises when a company owns both a PBM and a pharmacy. That has ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The dispute centers on ...
Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. But while Trump personally used that method to cast his vote in a Florida special ...
JOHNSTOWN, Pa. (WTAJ) — Thousands of patients are still separated from a community pharmacy chain in Cambria, Somerset and Westmoreland counties after a 2025 decision by a global health company left ...
For respondents facing novel Federal Trade Commission theories, the lesson is that early engagement—not reflexive litigation—can yield outcomes that address regulatory concerns while preserving ...
Nation’s largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates from PBM customers. NEW YORK--(BUSINESS WIRE)--Today, Bernstein Litowitz Berger & ...
A Settlement, Not a Sigh of Relief: What the FTC’s Express Scripts Deal Signals for Enforcement Risk
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
On February 4, 2026, the Federal Trade Commission (FTC) announced what it called a “landmark” settlement with Express Scripts, Inc. (ESI) in its enforcement action alleging anticompetitive practices ...
The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...
The Federal Trade Commission has reached a landmark settlement with Express Scripts, one of the nation’s largest pharmacy benefit managers, requiring sweeping changes aimed at lowering insulin costs ...
The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...
The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results